The striatum has important roles in motor control and action learning and, like many brain regions, receives multiple monoaminergic inputs. We have examined serotonergic modulation of rat and mouse corticostriatal neurotransmission and find that serotonin (5-HT) activates 5-HT 1b receptors resulting in a long-term depression (LTD) of glutamate release and striatal output that we have termed 5-HT-LTD. 5-HT-LTD is presynaptically mediated, cAMP pathway dependent, and inducible by endogenous striatal 5-HT, as revealed by application of a selective 5-HT reuptake inhibitor. 5-HT-LTD is mutually occlusive with dopamine/endocannabinoid-dependent LTD, suggesting that these two forms of LTD act on the same corticostriatal terminals. Thus, serotonergic and dopaminergic mechanisms exist that may interact to persistently sculpt corticostriatal circuits, potentially influencing action learning and striatal-based disorders.
Introduction
A single monoamine neurotransmitter, such as serotonin (5-HT) or dopamine, can potently modulate the strength of various synapse types within a nucleus. A common theme in brain, however, is the convergent release of multiple monoamine neurotransmitters to a given region. This configuration requires an understanding of how multiple monoamine-dependent mechanisms may interact to modulate synaptic potentials to ultimately dictate the output of a given nucleus.
The dorsal striatum, a basal ganglia structure necessary for action selection and habit formation, receives dual monoaminergic input; dopaminergic innervation originating from the substantia nigra pars compacta and serotonergic innervation arising from the dorsal raphe nucleus (DRN) (Steinbusch et al., 1981) . Striatal dopamine modulates the primary excitatory input to striatum: glutamatergic cortical fibers that abundantly synapse onto the dendritic spine heads of GABAergic medium spiny projection neurons (MSNs). Dopamine signaling through the D 2 dopamine receptor is necessary for the mobilization of endocannabinoids (eCBs) from MSNs that act retrogradely to induce a long-term depression (eCB-LTD) of glutamatergic synaptic transmission (Gerdeman et al., 2002; Kreitzer and Malenka, 2005) . This form of plasticity at the corticostriatal synapse is implicated in normal voluntary movement and skill learning and is lost in parkinsonism .
Although important aspects of dopaminergic modulation of the corticostriatal synapse have been illuminated, serotonergic effects on this synapse are not well understood. 5-HT fibers predominately terminate as nonjunctioning axo-axonic varicosities but also form axospinous or axodendritic asymmetric synapses on presumed MSNs (Soghomonian et al., 1989) . Several 5-HT receptor subtypes are localized to the dorsal striatum, including 5-HT 1a , 5-HT 1b , 5-HT 1d , 5-HT 1e , 5-HT 2a , 5-HT 1c , 5-HT 3a , 5-HT 4 , 5-HT 5a , 5-HT 6 , and 5-HT 7 (Di Matteo et al., 2008) . This ultrastructural configuration and receptor expression profile, coupled with findings showing that subsets of DRN serotonergic cells fire coincidently with the initiation and termination of selected voluntary movements (Fornal et al., 1996) , suggest a role for direct serotonergic modulation of synaptic transmission onto striatal MSNs.
To explore this possibility and potential interactions between serotonergic effects and dopamine-dependent plasticity, we examined the effect of 5-HT on glutamatergic signaling onto MSNs and net striatal output in rodent corticostriatal slices. We found that application of 5-HT, or selective 5-HT transporter reuptake blockade, induces LTD of glutamatergic signaling at corticostriatal synapses (5-HT-LTD) that reciprocally occludes eCB-LTD. These findings reveal a unique monoaminergic mechanism controlling presynaptic inhibition of corticostriatal glutamate release, a phenomenon that offers new insight into how dopamine and 5-HT systems may interact to influence striatum-dependent processes.
Materials and Methods
Brain slice preparation. After anesthetization of P14 -P18 Sprague Dawley rats or D 1 enhanced green fluorescent protein (GFP) BAC transgenic mice (GENSAT) (Heintz, 2004) , brains were removed, and 300-mthick (whole-cell recordings) or 350-m-thick (field potential recordings) coronal sections through the striatum were prepared using a vibratome (Leica Microsystems). Sections were equilibrated for 30 min (slices for field potential recordings) or 1 h (slices for whole-cell recordings) at 33°C in 95% CO 2 /5% O 2 bubbled artificial CSF (aCSF) containing the following (in mM): 124 NaCl, 4.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 26 NaHCO 3 , 1.2 NaH 2 PO 4 , and 10 glucose. Sections were subsequently incubated in the same solution at 24°C.
Whole-cell voltage-clamp recordings. Electrodes of 2-5 m⍀ resistance were pulled from borosilicate glass on a Flaming/Brown micropipette puller (Sutter Instruments). Pipettes were filled with a CsMeSO 3 -based solution of 295-300 mOsm (in mM: 120 CsMeSO 3 , 5 NaCl, 10 tetraethylammonium-Cl, 10 HEPES, 5 QX-314, 1.1 EGTA, 0.3 Na-GTP, and 4 Mg-ATP for ESPC recordings) and a CsCl-based solution of 295-300 mOsm (in mM: 150 CsCl, 10 HEPES, 2 MgCl 2 , 0.3 Na-GTP, 5 QX-314, 3 Mg-ATP, and 0.2 BAPTA for IPSC recordings). All recordings were performed between 29°C and 31°C and in the presence of picrotoxin (50 M). Striatal MSNs were held at Ϫ60 mV, and nucleus accumbens core MSNs were held between Ϫ70 and Ϫ75 mV, using a Multiclamp 700A amplifier (Molecular Devices). A bipolar concentric stimulating electrode (World Precision Instruments) was used to elicit EPSCs with amplitudes between 300 and 600 pA every 20 s. The stimulating electrode was placed at the border of the white matter of the external capsule and the dorsolateral striatum for dorsolateral striatum recordings. For the dorsomedial striatum, recordings were performed from MSNs just lateral to the dorsolateral-most point of the lateral ventricle, whereas the stimulating electrode was placed at the border of the overlying corpus callosum and striatum. For nucleus accumbens recordings, the recording electrode was placed just lateral to the anterior commisure fiber bundle, whereas the stimulating electrode was situated just lateral to the recording electrode; both the recording and stimulating electrodes were within the core of the nucleus accumbens. Recordings of EPSCs or IPSCs were filtered at 2 kHz and digitized at 10 kHz. Data were acquired using Clampex 9.2 (Molecular Devices). Experiments were discarded if series resistance varied by Ͼ15% or increased over 22 M⍀. The sensitivity to detect changes in ESPC amplitude was not affected across the ranges of baseline EPSC amplitude and series resistances used.
Extracellular recordings. Extracellular field potential recordings were performed using recording electrodes of 2-5 m⍀ resistance filled with 0.9% NaCl. Slice preparation and recording chamber parameters followed whole-cell methods above. A bipolar twisted tungsten electrode delivered test pulses every 30 s (0.03 Hz) to elicit population spikes (PSs). All other protocols were performed as described previously (Yin et al., 2007) .
Two-photon laser scanning microscopy and glutamate uncaging. A combined Two-photon laser scanning microscopy (2PLSM) and glutamate uncaging (2PLSU) microscope was used to uncage 4-methoxy-7-nitroindolinyl-caged L-glutamate (MNI-glutamate) and image dendritic spines of striatal MSNs filled with Alexa Fluor-594 (20 M) through the patch pipette from 200 m rat coronal hemisections superfused with aCSF maintained at 29°C. One titanium:sapphire laser (Chameleon Ultra II; Coherent) was tuned to 720 nm to photoactivate bath-applied MNI-glutamate (2.5 mM), whereas a second identical laser was tuned to 810 nm to excite Alexa Fluor-594 for imaging cellular morphology. All other instrumentation was used as described previously (Carter and Sabatini, 2004) . Alexa Fluor-594 was dissolved in the CsMeSO 3 -based solution described above and 10 -15 min passed to allow for dye equilibration. 2PLSU pulses at 500 s, electrical stimulation, and 2PLSM image acquisitions were executed sequentially, with one sequence defined as the following: electrical stimulation delivery, 10 s pause, 2PLSM imaging, 10 s pause, 2PLSU pulse delivery, 20 s pause.
Statistical analysis. Mean amplitude of EPSCs, IPSCs, and PSs were measured in Igor Pro, Clampex 9.2, or Clampfit 9.2, and the data were analyzed in GraphPad Prism (GraphPad Software). PS amplitude was defined as the relative difference between the peak of the early positivity and the peak negativity. EPSC, IPSC, and PS amplitudes were averaged per minute, expressed as percentage of average baseline amplitude, and compared using a two-tailed Student's t test. A one-way ANOVA followed by post hoc Dunn's test was used to analyze selected sets of spontaneous EPSC (sEPSC) and miniature EPSC (mEPSC) data.
Drugs. 5-HT, picrotoxin, and QX-314 were purchased from SigmaAldrich. Cell-impermeant BAPTA, tetracesium salt (molecular weight of 1004.03) was purchased from Invitrogen. All other drugs were purchased from Tocris Bioscience.
Results

Exogenous 5-HT-LTD
Effects of 5-HT on glutamatergic transmission onto MSNs in the dorsolateral or dorsomedial striatum were examined by measuring evoked EPSC (eEPSC) amplitudes in each subregion. The stimulating and recording electrode locations for both whole-cell and field potential recordings in the dorsolateral striatum are depicted in Figure 1a . After acquisition of a baseline recording, a 10 min bath application of 5 M 5-HT resulted in a significant depression of EPSC amplitude (5-HT-LTD) (EPSC amplitude at t ϭ 70 min, 54.08 Ϯ 9.9% of baseline; n ϭ 6; p Ͻ 0.0001) (Fig. 1a) . The observed depression was not a result of an increase in series resistance (Fig. 1b) . The EPSC amplitude decrease was long lasting and did not recover even 55 min after the cessation of 5-HT application, prompting us to designate this depression as 5-HT-LTD. The amplitude of EPSCs was stable in the absence of drug application (Fig. 1a) . Recording MSNs in the dorsomedial striatum, we found that 5 M 5-HT also significantly depressed EPSC amplitude (EPSC amplitude at t ϭ 25 min, 65.3 Ϯ 4.0% of baseline; n ϭ 8; p Ͻ 0.0001). 5-HT-LTD was observed in 26 of 28 dorsolateral cells and 8 of 8 dorsomedial MSNs.
The whole-cell data suggest that 5-HT-LTD may suppress striatal output. We examined effects of 5-HT application on net striatal output in acute corticostriatal slices using field potential recording. 5-HT (5 M, 10 min) application resulted in a depression of PS amplitude (PS amplitude at t ϭ 60 min, 59.5 Ϯ 9.4% of baseline; n ϭ 5; p ϭ 0.003) that persisted after 5-HT removal (Fig.  1c) . 5-HT is also known to excite GABAergic striatal fast-spiking interneurons (Blomeley and Bracci, 2009) , cells that potently inhibit MSN firing by directly innervating MSN somata (Tepper et al., 2008) . To determine whether increased GABA A receptor signaling contributes to 5-HT-induced PS depression, which primarily derives from MSN responses, we applied 5-HT (5 M, 10 min) in the constant presence of picrotoxin (50 M). A lasting depression of PS amplitude was observed (PS amplitude at t ϭ 60 min, 58.6 Ϯ 5.2% of baseline; n ϭ 5; p Ͻ 0.0001) (Fig. 1d) . The PS amplitude was stable in the presence or absence of picrotoxin ( Fig. 1c,d ).
5-HT-LTD is mediated by 5-HT 1b receptors and presynaptically expressed
We next sought to determine the 5-HT receptor subtype mediating 5-HT-LTD. Application of the 5-HT 1b receptor-selective agonist CP 93129 (2 M, 10 min) induced LTD of EPSC amplitude in whole-cell recordings from the dorsolateral striatum (EPSC amplitude at t ϭ 40 -45 min, 61.2 Ϯ 3.1% of baseline; p Ͻ 0.0001; n ϭ 5) (Fig. 2a) . CP 93129-induced depression was subsequently partially reversed by the 5-HT 1b -specific antagonist NAS-181 (20 M) compared with the NAS-181-free control [t ϭ 40 -45 min, 76.3 Ϯ 2.1% (NAS-181) of baseline; p ϭ 0.004; n ϭ 5]. Despite this partial reversal, EPSC amplitude remained depressed compared with baseline (t ϭ 40-45 min; p Ͻ 0.0001; n ϭ 5) (Fig. 2a) , indicating that CP 93129-induced lasting depression is not a result of lingering 5-HT 1b activation. The 5-HT 1a agonist 8-hydroxy-2(di-n-propylamino)tetralin (20 M) did not alter responses (EPSC amplitude at t ϭ 25 min, 102.2 Ϯ 13.8% of baseline; p ϭ 0.9; n ϭ 3). To rule out involvement of other 5-HT receptor subtypes in 5-HT-LTD, we applied 5-HT (5 M, 10 min) in the continuous presence of . This treatment completely blocked 5-HT-LTD (vs baseline at t ϭ 25 min, 102.6 Ϯ 10.3%; p ϭ 0.8; n ϭ 5) (Fig. 2b) . Application of the mixed 5-HT 1b and 5-HT 2 receptor agonist TCB-2 (2 M, 10 min) (Best and Regehr, 2008 ) also persistently depressed EPSC amplitude (vs baseline at t ϭ 25 min, 72.8 Ϯ 5.6%; p ϭ 0.001; n ϭ 5), and this effect was blocked in the continuous presence of NAS-181 (5 M) (vs baseline at t ϭ 25 min, 94.7 Ϯ 8.2%; p ϭ 0.5; n ϭ 4). Thus, 5-HT 1b appears to be the receptor subtype responsible for 5-HT-LTD.
Next, we examined whether 5-HT-LTD is expressed presynaptically or postsynaptically. We first examined whether CP 93129 depressed EPSC amplitude evoked by 2PLSU of MNIglutamate (uEPSCs) at single MSN dendritic spine heads, which were visualized using 2PLSM. Stimulating electrode eEPSCs (alternated with uEPSCs) were used as a positive control. CP 93129 application did not depress uEPSC amplitude (vs baseline at t ϭ 15 min, 91.6 Ϯ 10%; p ϭ 0.4; n ϭ 7) but depressed eEPSC amplitude onto the same cell (vs baseline at t ϭ 10 -15 min, 43.2 Ϯ 8.5%; p Ͻ 0.0001; n ϭ 7) (Fig. 3a) . eEPSC amplitude was significantly depressed compared with uEPSC amplitude (t ϭ 10 -15 min vs uEPSC; p ϭ 0.0026; n ϭ 7), suggesting that 5-HT-LTD is presynaptically expressed. Next, we delivered pairedpulse stimulation at a 50 ms interpulse interval every 20 s and applied CP 93129 (2 M). CP 93129 (2 M, 10 min) increased the paired-pulse ratio (PPR) (EPSC2/EPSC1) compared with baseline (mean EPSC2/EPSC1 amplitude: baseline, 1.22 Ϯ 0.06 vs CP 93129, 1.42 Ϯ 0.09; p ϭ 0.02; n ϭ 8) (Fig. 3b) , suggesting a decrease in transmitter release probability. Presynaptically expressed LTD should also affect NMDA receptor-dependent EPSCs (NMDAR-EPSCs), and we examined this by applying the AMPAR antagonist NBQX (5 M) and recording at a Ϫ40 mV holding potential. Bath application of CP 93129 (2 M) persistently depressed NMDAR-EPSC amplitude (t ϭ 25-30 min, 21.4 Ϯ 1.0% of baseline; p Ͻ 0.0001; n ϭ 5) (Fig. 3c) . To further examine potential postsynaptic mechanisms in 5-HT-LTD, we loaded the postsynaptic cell with the calcium chelator BAPTA (20 mM) through the recording pipette. Postsynaptic BAPTA did not block 5-HT actions (t ϭ 25 min, 48.8 Ϯ 7.6% of baseline; p ϭ 0.0005; n ϭ 5) (Fig. 3d) .
We next examined the effect of CP 93129 (2 M, 10 min) on the frequency and amplitude of TTX-insensitive mEPSCs and sEPSCs before (baseline), during (CP 93129), and 20 -25 min after (wash) CP 93129 application (Fig.  4a) . CP 93129 significantly increased mEPSC (Fig. 4b) and sEPSC interevent interval (IEI) over baseline values (mEPSC: baseline, 0.47 Ϯ 0.08 s vs CP 93129, 0.76 Ϯ 0.1 s, n ϭ 8, p Ͻ 0.05; sEPSC: baseline, 0.33 Ϯ 0.04 s vs CP 93129, 0.60 Ϯ 0.13 s, n ϭ 6, p Ͻ 0.05). Despite 20 -25 min of drug washout, the average IEI remained significantly increased over baseline (mESPC: wash, 0.84 Ϯ 0.17 s, n ϭ 8, p Ͻ 0.05; sEPSC: wash, 0.82 Ϯ 0.2 s, n ϭ 6, p Ͻ 0.01). mEPSC and sEPSC IEI averages were not significantly different between drug and washout conditions ( p Ͼ 0.05). The average mEPSC (Fig. 4c) and sEPSC amplitude in either the drug or washout conditions did not differ significantly from baseline values (mEPSC: baseline, 26.3 Ϯ 0.7 pA vs CP 93129, 27 Ϯ 0.7 pA; or baseline vs washout, 24.8 Ϯ 1.2 pA, n ϭ 8, p Ͼ 0.05; sEPSC: baseline, 26.9 Ϯ 3 pA vs CP 93129, 25.3 Ϯ 2.4 pA; or baseline vs washout, 23.6 Ϯ 2.5 pA, n ϭ 6, p Ͼ 0.05). Importantly, application or washout of CP 93129 did not change postsynaptic holding current (Fig. 4d) .
5-HT-LTD is independent of cannabinoid receptor 1 activation
The classical form of LTD at striatal glutamatergic synapses requires retrograde eCB signaling (Gerdeman et al., 2002) , and this system can be co-opted by neurotensin in the striatum in a similar manner to 5-HT-induced eCB release in the olivary nucleus (Best and Regehr, 2008; Yin et al., 2008) . We, therefore, tested whether 5-HT-LTD is mediated by cannabinoid receptor 1 (CB 1 ) activation. As a positive control for the actions of the CB 1 antagonist AM251, we examined the ability of the antagonist to block CB 1 -agonist-induced synaptic depression. After a 5 min baseline period, we applied the CB 1 agonist WIN 55,212-2 for 10 min with or without AM251 (3 M) present during the entire experiment. The WIN 55,212-2-induced depression of EPSC amplitude (vs baseline at t ϭ 15 min, 72.6 Ϯ 4.4%; p Ͻ 0.0001; n ϭ 5) was completely blocked by AM251 (vs baseline at t ϭ 15 min, 96.7 Ϯ 1.9, p ϭ 0.2, n ϭ 5; vs WIN 55, 212-2 alone at t ϭ 15 min, p ϭ 0.001) (Fig. 5a ). To test whether 5-HT-LTD is indeed mediated by CB 1 , we applied 5-HT (5 M) or CP 93129 (2 M) in the presence of the CB 1 antagonist AM251 (3 M). CB 1 activation was unnecessary for 5-HT-or CP 93129-induced depression of EPSC amplitude (t ϭ 25 min: 5-HT, 70.4 Ϯ 4.9% of baseline, p ϭ 0.0009, n ϭ 5; CP 93129, 57.6 Ϯ 6% of baseline, p Ͻ 0.0001, n ϭ 6) (Fig. 5b,c) .
5-HT-LTD at other synapses
The striatum heavily expresses 5-HT 1b transcript (Maroteaux et al., 1992) , and the 5-HT 1b receptor protein was shown to be present on MSN axon terminals (Boschert et al., 1994) . However, no reduction in GABAergic IPSC amplitude in dorsolateral MSNs was observed after the same 10 min application of 5 M 5-HT (IPSC amplitude at t ϭ 25 min, 90.4 Ϯ 10.8% of baseline; n ϭ 7; p ϭ 0.4) (Fig. 6a) . Because MSN axon collaterals impinge on other MSNs, it was interesting that we did not observe 5-HT-LTD at GABAergic synapses on MSNs after 5-HT application. Therefore, we tested whether selective 5-HT 1b activation, presumably on MSN collateral terminals, could induce LTD. CP 93129 (2 M, 10 min) application depressed IPSC amplitude recorded in the dorsolateral striatum (vs baseline t ϭ 30 -35 min, 59.2 Ϯ 9.1%; p ϭ 0.002; n ϭ 6) (Fig. 6b) .
Because 5-HT application has been demonstrated to result in a reversible inhibition of glutamate release in the nucleus accumbens (Muramatsu et al., 1998) , we examined the effects of CP 93129 on evoked EPSCs recorded from MSNs of the nucleus accumbens core. CP 93129 (2 M, 10 min) resulted in a rapid and lasting depression of EPSC amplitude (vs baseline at t ϭ 30 -35 min, 47.3 Ϯ 8.3%; p ϭ 0.0002; n ϭ 6) (Fig. 6c) . After 20 min of drug washout (red circles), the IEI remained significantly greater than baseline (wash) (n ϭ 6). C, mEPSC amplitude was not significantly different across conditions (n ϭ 6). D, Traces of example striatal MSN recordings show that the holding current did not change during bath application of CP 93129 (2 M) (top) or by washout of CP 93129 (2 M) (bottom). Calibration: A, 30 pA, 1 s.
Endogenous 5-HT-LTD
To determine whether 5-HT-LTD is inducible by endogenous 5-HT in the acute slice preparation, we bath applied the selective 5-HT reuptake inhibitor (SSRI) citalopram (4 M) for 10 min. Citalopram significantly depressed EPSC amplitude (vs baseline at 30 -35 min, 61.8 Ϯ 8.5%; p ϭ 0.002; n ϭ 5) (Fig. 7a) . When examining the individual cell data, three of five cells displayed LTD, whereas two showed no depression (Fig. 7a) . To promote a more reliable SSRI-induced LTD for experiments examining receptor dependence, we applied citalopram (4 M) along with a burst stimulation protocol consisting of six pulses (50 ms interpulse interval) every 20 s for 10 min in an attempt to nonselectively activate serotonergic fibers through current spread from the stimulating electrode. This stimulation protocol began 3 min after the onset of citalopram application and ended 3 min after beginning drug washout (membrane potential was maintained at Ϫ60 mV). The same stimulating electrode was used to elicit test pulses and burst stimulation. We chose this burst stimulation frequency because responses fully recovered to baseline levels 5-10 min after cessation of burst stimulation alone (vs baseline at t ϭ 30 -35 min, 93 Ϯ 5.8%; p ϭ 0.3; n ϭ 6) (Fig. 7b) . Thus, this pattern of stimulation by itself is not sufficient to induce any form of LTD. Citalopram coupled with the burst stimulation protocol (Cit-Burst) consistently and persistently depressed EPSC amplitude (six of six cells) (t ϭ 35 min, 73 Ϯ 3.2% of baseline; p Ͻ 0.0001; n ϭ 6) (Fig.  7b) . The CB 1 antagonist AM251 (3 M) was present throughout the experiment to exclude possible CB 1 -mediated effects. In subsequent experiments we used the CitBurst paradigm, as opposed to citalopram alone, to ensure that LTD was consistently induced.
To determine whether the 5-HT 1b receptor also mediated the Cit-Burst-induced LTD, we applied Cit-Burst in the presence of the 5-HT 1b antagonist NAS-181 (20 M). This endogenous 5-HT-LTD was completely blocked by NAS-181 (vs baseline at t ϭ 30 -35 min, 93.3 Ϯ 5.2%, p ϭ 0.1, n ϭ 5; vs no NAS-181 at t ϭ 30 -35 min, 58.5 Ϯ 5.2%, p ϭ 0.002, n ϭ 5), indicating that 5-HT 1b mediates this effect (Fig. 7c) . To ensure that blockade of 5-HT-LTD was achieved by 5-HT 1b antagonism alone, AM251 was not applied. To further rule out involvement of calcium-mediated postsynaptic eCB release in the expression of endogenous 5-HT-LTD, we loaded the postsynaptic cell with BAPTA (20 mM). Cit-Burst produced persistent depression of EPSC amplitude under this condition (vs baseline at t ϭ 25 min, 56.6 Ϯ 14.8%; p ϭ 0.02; n ϭ 6).
5-HT-LTD is not pathway specific
To assess whether 5-HT-LTD is specific to either the direct or indirect output pathways of the striatum, we recorded in slices prepared from BAC-transgenic mice expressing GFP under control of the D 1 dopamine receptor promoter. CP 93129 (2 M, 10 min) persistently depressed EPSC amplitude in D 1 -containing (GFP-positive) (vs baseline at t ϭ 35 min, 62.2 Ϯ 6.9%; p Ͻ 0.0001; n ϭ 10) and putative D 2 -containing (GFP-negative) cells (vs baseline at t ϭ 35 min, 66.2 Ϯ 8.3%; p Ͻ 0.0001; n ϭ 10) (Fig. 8a) . Cit-Burst also persistently depressed averaged EPSC amplitude in both D 1 -containing (vs baseline at t ϭ 35 min, 71.2 Ϯ 7.9%; p Ͻ 0.0001; n ϭ 10) and putative D 2 -containing (vs baseline at t ϭ 35 min, 69.7 Ϯ 6.8%; p Ͻ 0.0001; n ϭ 10) MSNs (Fig. 8b) . Interestingly, three D 1 -containing cells and two putative D 2 -containing cells exhibited a transient depression of EPSC amplitude. 
5-HT-LTD is cAMP pathway dependent
5-HT 1b , a G i /G o -coupled receptor, is reported to negatively couple to adenylyl cyclase (AC) (Bouhelal et al., 1988) . To explore whether 5-HT-LTD is indeed AC dependent, we applied forskolin (10 -20 M), an activator of AC. Forskolin application alone increased EPSC amplitude (vs baseline at t ϭ 25 min, 126.8 Ϯ 9.1%; p ϭ 0.03; n ϭ 6) (Fig. 9a) . After incubating slices for at least 15 min in 10 -20 M forskolin, we applied CP 93129 (2 M) for 4 min and observed initial, but not persistent, depression of EPSC amplitude (t ϭ 25 min, 95.4 Ϯ 5% of baseline; p ϭ 0.4; n ϭ 6) (Fig. 9b) , whereas CP 93129 (2 M, 4 min) without forskolin persistently depressed EPSC amplitude (t ϭ 25 min, 59.3 Ϯ 3.6% of baseline; p Ͻ 0.0001; n ϭ 5). Because AC catalyzes the conversion of ATP to cAMP, we examined whether cAMP saturation might prevent 5-HT-LTD. Bath application of 8-Br-cAMP (80 M), a cell-permeable cAMP analog, blocked CP 93129-induced LTD (vs baseline at t ϭ 25 min, 90.8 Ϯ 8%; p ϭ 0.35; n ϭ 5), suggesting that 5-HT-LTD works through the cAMP-dependent pathway (Fig. 9c) .
5-HT-LTD and eCB-LTD are mutually occlusive
Thus far, 5-HT-LTD and eCB-LTD both appear to activate presynaptic G i /G o -coupled receptors (5-HT 1b and CB 1 ). Because both 5-HT 1b and CB 1 engage similar post-receptor signaling pathways (Bouhelal et al., 1988; Davis et al., 2003) , we reasoned that if 5-HT 1b and CB 1 were on the same population of corticostriatal terminals then eCB-LTD and 5-HT-LTD may be mutually occlusive. To examine this, we first induced eCB-LTD with a high-frequency stimulation protocol (HFS) consisting of four 100 pulse trains (every 10 s) with an interpulse interval of 10 ms (100 Hz for 1 s) while depolarizing the cell to a 0 mV holding potential. HFS induced a depression of EPSC amplitude (t ϭ 14 min, 74.4 Ϯ 6.6% of baseline; p ϭ 0.005; n ϭ 5) (Fig. 10a) . During stabilization of EPSC amplitude after HFS, we then applied CitBurst to induce 5-HT-LTD. Cit-Burst induced a minor, additional depression that was not significantly different from EPSC amplitude after HFS alone (EPSC amplitude at t ϭ 14 min vs t ϭ 35 min, 59.5 Ϯ 8.9% of the original pre-HFS baseline; p ϭ 0.2; n ϭ 5).
To examine whether 5-HT-LTD occludes eCB-LTD, we applied Cit-Burst, which again induced LTD of EPSC amplitude compared with baseline (t ϭ 25 min, 63.5 Ϯ 6.4%; p ϭ 0.0005; n ϭ 5) (Fig. 10b) . After stabilization of EPSC amplitude, we then delivered HFS. Compared with EPSC amplitude after Cit-Burst, HFS did not induce an additional depression (EPSC amplitude t ϭ 25 min vs t ϭ 45 min, 67.1 Ϯ 4.9%; p ϭ 0.7; n ϭ 5), showing eCB-LTD and 5-HT-LTD to be mutually occlusive. It is possible that some eCBs are released by the burst component of Cit-Burst, and this could decrease the ability of HFS to induce an additional eCB-dependent depression after Cit-Burst. Thus, we bath applied CP 93129 (2 M), waited for stabilization of the EPSC amplitude, and then delivered HFS. CP 93129 (2 M) alone depressed the EPSC amplitude (vs baseline at t ϭ 24 min, 51.7 Ϯ 6.6%; p Ͻ 0.0001; n ϭ 5). HFS did not further depress EPSC amplitude after CP 93129 application (EPSC amplitude t ϭ 24 min vs t ϭ 45 min, 40.8 Ϯ 6.5%; p ϭ 0.3; n ϭ 5) (Fig. 10c) , showing that this route to 5-HT-LTD also occludes eCB-LTD.
Discussion
We show that exogenously applied or endogenous 5-HT induces a presynaptically expressed, 5-HT 1b -dependent LTD of glutamatergic transmission (5-HT-LTD) in the dorsal striatum that culminates in a depression of net striatal output. 5-HT-LTD is cAMP pathway dependent and, within the striatum, represents a novel pathway to lasting depression that parallels and occludes the dopamine-dependent, eCB-mediated LTD.
Mutual occlusion between 5-HT-LTD and eCB-LTD, increased PPR, and decreased sEPSC and mEPSC frequencies indicate a presynaptic mechanism of 5-HT-LTD expression, perhaps involving a decrease in probability of glutamate release. In contrast, mEPSC and uEPSC amplitudes were not affected, and postsynaptic manipulations, particularly BAPTA loading, did not prevent 5-HT-LTD induction. This evidence for presynaptic 5-HT 1b localization is supported by electron microscopic, electrophysiological, and neurochemical studies that revealed that 5-HT 1b receptors are localized to presynaptic terminals and act as autoceptors or heteroceptors in several brain regions (Sari et al., 1999; Morikawa et al., 2000) . Considering that application of 5-HT, a 5-HT 1b agonist, and citalopram all induce LTD, the most parsimonious explanation of these findings is that 5-HT-LTD induction involves 5-HT acting heterosynaptically on 5-HT 1b receptors localized on corticostriatal terminals.
It should be noted that our glutamate uncaging experiment could be confounded by sample bias through inadvertent examination of 5-HT 1b -unresponsive synapses on spines. However, it is unlikely that we would have consistently observed no change in uEPSCs given the strong 5-HT 1b agonist inhibition of eEPSCs. To minimize eEPSC and uEPSC amplitude disparity, and thus synapse selection disparity, we used electrical stimulation parameters that evoked the smallest-amplitude eEPSCs that showed acceptable consistency. Because all corticostriatal synapses are on MSN spines and a band of 5-HT 1b mRNA-positive cell bodies is visible in layer V of mouse cortex whereas no signal is apparent in the thalamic intralaminar nuclei (Allen Brain Atlas; http://www. brain-map.org/), we would have expected to observe depression in most, if not all, of the uEPSCs. Thus, although we cannot fully rule out an effect of sample bias, we feel that it is unlikely to account for our findings.
Reversible inhibition of glutamate release has been demonstrated during 5-HT application in the nucleus accumbens (Muramatsu et al., 1998) . We showed that 5-HT-LTD is not a consequence of residual agonism by applying the 5-HT 1b antagonist NAS-181 after induction and stabilization of EPSC amplitude depression. We also observed 5-HT-LTD at inhibitory synapses onto dorsolateral MSNs and at glutamatergic synapses onto MSNs of the nucleus accumbens core. Interestingly, we observed a reversible inhibition during Cit-Burst delivery in a few D 1 -containing and putative D 2 -containing cells recorded from mouse slices and in all cells when CP 93129 was applied in the presence of forskolin. The reversible effect was not seen in mouse slices when we applied CP 93129 alone. This suggests that the duration and concentration of 5-HT 1b activation, and coupling to downstream AC, may be critical in governing the transition from short-to long-term inhibition of glutamate release.
Although 5-HT-LTD and eCB-LTD share the common feature of presynaptic G i /G o -coupled signaling and depression of neurotransmitter release, 5-HT-LTD is a unique form of plastic- ity in brain because of its distinct requirements for induction. Unlike eCB-LTD, which is mediated by retrograde eCB signaling (Gerdeman et al., 2002) , our postsynaptic manipulation data indicate that retrograde signaling is not involved in the induction of 5-HT-LTD. This is important because both presynaptic activity and postsynaptic calcium influx appear to be required for eCB-LTD (Singla et al., 2007; Adermark et al., 2009) , indicating synapse specificity, and, thus, a "Hebbian" form of plasticity. In the contrasting case of 5-HT-LTD, our data suggest that presynaptic corticostriatal action potential firing is unnecessary for 5-HT-LTD induction. Because all of our experiments involved a constant holding potential during recordings and a sodium channel blocker (QX-314) in a cesium-based internal solution, we can assume that postsynaptic activity is not necessary for 5-HT-LTD induction. Without the need for presynaptic or postsynaptic activity, 5-HT-LTD appears to be non-Hebbian.
DRN firing is implicated in the control of actions (Fornal et al., 1996; Jacobs and Fornal, 1999) . Single-unit recordings from freely moving cats demonstrated significant firing increases in subsets of serotonergic DRN neurons preceding initiation of oral-buccal movements, resumption of normal firing rates during termination of motor sequences (Fornal et al., 1996) , and abrupt decreases in DRN activity to levels at or below baseline that are tightly correlated with spontaneous pauses in motor sequences. The notion of striatal 5-HT influencing action control is consistent with the clinical use of SSRIs for the treatment of obsessive-compulsive disorder (Goddard et al., 2008) . Genetic deletion of the corticostriatal synapse-specific protein SAPAP3 results in an obsessive-compulsive disorder-like behavioral phenotype that is alleviated by SSRI treatment (Welch et al., 2007) . In the context of the present findings, the dynamic interaction of striatal 5-HT-LTD and eCB-LTD is a candidate mechanism for the long-term filtering of corticostriatal input enabling proper action selection that may also represent a point of perturbation by therapeutic and illicit drugs (Rocha et al., 1998) .
